Response Genetics Overview
- Year Founded
-
1999

- Status
-
Public
- Employees
-
237

- Stock Symbol
-
RGDXQ

- Investments
-
1
Response Genetics General Information
Description
Response Genetics Inc develops and sells diagnostic tests. It provides molecular- and biomarker-based tests and services which enables physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment. The group generates revenue from providing Biopharma Services, Clinical Services, and Discovery Services, of which majority of the revenue is derived from providing Biopharma Services. Biopharma services provide companies with customized solutions for patient stratification and treatment selection through molecular- and biomarker-based testing services, customized assay development and trial design consultation. The firm operates in the US and internationally and generates prime revenue from the US.
Contact Information
Website
www.responsegenetics.comCorporate Office
- 1640 Marengo Street
- Sixth Floor
- Los Angeles, CA 90033
- United States
Corporate Office
- 1640 Marengo Street
- Sixth Floor
- Los Angeles, CA 90033
- United States
Response Genetics Stock Performance
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
1.14K |
Response Genetics Financials Summary
As of 31-Dec-2015, Response Genetics has a trailing 12-month revenue of $18M.
In Thousands, USD |
TTM 31-Dec-2015 | FY 2015 31-Dec-2015 | FY 2014 31-Dec-2014 | FY 2013 31-Dec-2013 |
---|---|---|---|---|
EV | 9,243 | 9,243 | 15,976 | 36,487 |
Revenue | 18,040 | 18,040 | 10,199 | 6,610 |
EBITDA | (19,411) | (19,411) | (17,756) | (10,353) |
Net Income | (20,184) | (20,184) | (16,643) | (12,373) |
Total Assets | 48,884 | 48,884 | 47,105 | 18,058 |
Total Debt | 6,373 | 6,373 | 6,919 | 1,294 |
Response Genetics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Response Genetics Comparisons
Industry
Financing
Details
Response Genetics Competitors (25)
One of Response Genetics’s 25 competitors is Revvity, a Corporation company based in Waltham, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Revvity | Corporation | Waltham, MA | ||||
Hain Lifescience | Corporate Backed or Acquired | Nehren, Germany | ||||
Oxford Immunotec | Formerly VC-backed | Abingdon, United Kingdom | ||||
HealthBioAI | Venture Capital-Backed | Hayward, CA | ||||
Sysmex (Diagnostic Equipment) | Corporation | Kobe, Japan |
Response Genetics Patents
Response Genetics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2011240653-A1 | Kras primers and probes | Inactive | 12-Apr-2010 | ||
EP-2558595-A2 | Kras primers and probes | Inactive | 12-Apr-2010 | ||
AU-2010282632-A1 | Methods, primers, probes and kits useful for the detection of braf mutations | Inactive | 11-Aug-2009 | ||
EP-2464751-A2 | Methods, primers, probes and kits useful for the detection of braf mutations | Active | 11-Aug-2009 | ||
EP-2464751-B1 | Methods, primers, probes and kits useful for the detection of braf mutations | Inactive | 11-Aug-2009 | C12Q1/6886 |
Response Genetics Signals
Response Genetics Acquisitions (1)
Response Genetics’s most recent deal was a Merger/Acquisition with Pathwork Diagnostics for . The deal was made on 26-Aug-2013.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Pathwork Diagnostics | 26-Aug-2013 | Merger/Acquisition | Diagnostic Equipment |
Response Genetics FAQs
-
When was Response Genetics founded?
Response Genetics was founded in 1999.
-
Where is Response Genetics headquartered?
Response Genetics is headquartered in Los Angeles, CA.
-
What is the size of Response Genetics?
Response Genetics has 237 total employees.
-
What industry is Response Genetics in?
Response Genetics’s primary industry is Diagnostic Equipment.
-
Is Response Genetics a private or public company?
Response Genetics is a Public company.
-
What is Response Genetics’s stock symbol?
The ticker symbol for Response Genetics is RGDXQ.
-
What is Response Genetics’s current revenue?
The trailing twelve month revenue for Response Genetics is $18M.
-
Who are Response Genetics’s competitors?
Revvity, Hain Lifescience, Oxford Immunotec, HealthBioAI, and Sysmex (Diagnostic Equipment) are some of the 25 competitors of Response Genetics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »